BCR and COVID-19: Despite these challenges, developing TCR repertoire-based clinical tests is important and complementary to serological and BCR-based tests, because we expect TCR repertoires to be more stable over time, and COVID-19 signatures to persist detectable in peripheral T cells longer than in antibody sera.